Melanotan 2

Melanotan 2 (MT-II) is a synthetic cyclic heptapeptide (Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-NH2) designed as a potent, nonselective melanocortin receptor agonist. Structurally derived from alpha-melanocyte-stimulating hormone (α-MSH), its cyclic configuration enhances receptor affinity and metabolic stability in experimental systems. In laboratory and controlled clinical research, Melanotan 2 is investigated for its activity across melanocortin receptor subtypes MC1R through MC5R, providing a model for studying G protein-coupled receptor (GPCR) signaling dynamics and peptide-receptor pharmacology under defined conditions.

In vitro systems and structured experimental investigations evaluate endpoints including receptor binding affinity, intracellular cAMP activation, GPCR desensitization mechanisms, melanogenesis-associated markers such as tyrosinase activity, and transcriptional responses linked to melanocortin pathway signaling relative to controls. Additional research explores hypothalamic melanocortin signaling, neuroendocrine pathway modulation, and receptor-specific signal transduction kinetics within defined molecular pharmacology frameworks.